Key result
HRRP implementation linked to ~10% relative drop in all-cause 30-day readmissions among Medicare beneficiaries.
Why the study?
Hospital readmissions are common, costly, and associated with poor outcomes, prompting the implementation of the Hospital Readmission Reduction Program to reduce 30-day readmissions for key conditions.
Does the Hospital Readmissions Reduction Program reduce 30-day readmission rates among Medicare beneficiaries?
Does the Hospital Readmissions Reduction Program reduce 30-day readmission rates among Medicare beneficiaries?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Although early data suggested that HRRP was improving care, new evidence suggests that the benefits may have been much smaller than understood and that there might have been meaningful, unintended consequences. One thing is becoming clear: HRRP is not working as well as its architects had hoped, and it is time to take a fresh look at the program.”
“More recent evidence, however, suggests that readmission reductions initially credited to the program were overstated, and instead, primarily due to nationwide changes in the coding intensity and statistical artifact, including regression to the mean and secular decreases in index admissions, rather than changes in care delivery.”
“We knew that some of the improvements in readmissions at penalized hospitals were due to regression to the mean as readmissions are determined both by care quality and random events such as a patient falls or bad weather. We wanted to know how much of the improved readmissions were due to regression to the mean versus improvements in quality of care. Answering this question is critical for understanding the true effects of Medicare's decision to penalize hospitals for excess readmissions.”
The HRRP policy has been associated with a reduction in 30-day hospital readmissions, though it raises concerns regarding the penalization of safety-net hospitals and unintended consequences.
Hospital readmission measures have been touted not only as a quality measure but also as a means to bend the healthcare cost curve. The Affordable Care Act (ACA) established the Hospital Readmission Reduction Program (HRRP) in 2012. Under this program, hospitals are financially penalized if they have higher-than-expected risk-standardized 30-day readmission rates for acute myocardial infarction, heart failure, and pneumonia. The HRRP has garnered significant attention from the medical community, both positive and negative. Here, we describe the reasons the HRRP was implemented, the penalties levied, the impact it has had on transitional care and readmissions, the pros and cons of the policy, and its future. Hospital readmissions are associated with unfavorable patient outcomes and high financial costs.1,2 Causes of readmissions are multifactorial, and rates vary substantially by institution.3,4 Historically, nearly 20% of all Medicare discharges had a readmission within 30 days.1 The Medicare Payment Advisory Commission has estimated that 12% of readmissions are potentially avoidable. Preventing even 10% of these readmissions could save Medicare $1 billion.5 Therefore, reducing hospital readmissions has been made a national priority. In 2008, the Medicare Payment Advisory Commission recommended to Congress that the Centers for Medicare & Medicaid Services (CMS) begin confidentially reporting readmission rates and resource use to hospitals and physicians.6 In 2009, CMS began publicly reporting hospital-level readmission rates, which were added to the Hospital Compare Web site.7 Before 2012, hospitals had little direct financial incentive to reduce readmissions. For Medicare beneficiaries with inpatient stays, hospitals receive payment with the inpatient prospective payment system (IPPS). This payment, based on a diagnosis-related group (DRG), covers the inpatient stay and any outpatient diagnostic and admission-related outpatient nondiagnostic services provided by the institution on the date of the patient’s admission or within 3 days immediately …
No takes yet. Share an insight, caveat, or question.
McIlvennan et al. (2015) conducted a review in Hospital readmissions (Acute myocardial infarction, heart failure, pneumonia). Hospital Readmissions Reduction Program (HRRP) vs. Pre-HRRP period was evaluated on All-cause 30-day readmission rate. The implementation of the Hospital Readmissions Reduction Program was associated with a decrease in the all-cause 30-day readmission rate among Medicare beneficiaries from 19.0-19.5% to 17.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: